<DOC>
	<DOCNO>NCT00149201</DOCNO>
	<brief_summary>To develop effective chemotherapy regimen gastric cancer peritoneal metastasis</brief_summary>
	<brief_title>A Study 5-FU Versus MTX+5-FU Gastric Cancer With Peritoneal Metastasis</brief_title>
	<detailed_description>Peritoneal metastasis common advance gastric cancer consider incurable disease state . Peritoneal metastasis may cause serious complication , intestinal obstruction , massive ascites , hydronephrosis associate clinical presentation abdominal pain fullness , vomit , constipation , malnutrition renal dysfunction.5-FU continuous infusion remain mainstay chemotherapy gastric cancer . On , sequential MTX+5-FU report effective advanced gastric cancer peritoneal metastasis phase II study . Therefore , randomize phase III study 5-FU versus sequential MTX+5-FU gastric cancer peritoneal metastasis conduct .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Stomach Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>1. histologic confirmation gastric adenocarcinoma 2. inoperable metastatic disease recurrent metastatic disease surgery 3. disease peritoneal metastasis 4 . 20 year less 75 year 5. performance status 2 less Eastern Cooperative Oncology Group scale 6. prior treatment gastric carcinoma except surgery adjuvant chemotherapy 7. prior chemotherapy radiotherapy disease except gastric cancer 8. adequate bone marrow function , adequate liver function , adequate renal function 9. prior transfusion anemia 10. provision write informed consent 1 . Massive pleural effusion 2. brain metastasis symptoms 3. severe diarrhea 4. severe medical condition ( infection , diabetes , hypertension , acute myocardial infarction , unstable angina , liver cirrhosis , intestinal pneumonia , pulmonary fibrosis ) 5. active malignancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2009</verification_date>
	<keyword>gastric cancer</keyword>
	<keyword>peritoneal metastasis</keyword>
	<keyword>randomize trial</keyword>
	<keyword>5-FU</keyword>
	<keyword>MTX</keyword>
</DOC>